Table 1.
Clinical Characteristics of Patients With Nocardial Brain Abscess
| Variables | Nocardial Brain Abscess Cases (n = 24) |
|---|---|
| Demographics, No. (%) | |
| Female | 6 (25) |
| Male | 18 (75) |
| Age, median (IQR), y | 64 (58.5–71.2) |
| Race (%) | |
| White | 23 (95.8) |
| Black or African American | 1 (4.2) |
| Comorbidities, No. (%) | |
| Malignancy | 13 (54.1) |
| Head and neck | 3 (12.5) |
| Chronic kidney disease | 11 (45.8) |
| Hemodialysis | 4 (16.6) |
| Essential hypertension | 8 (33.3) |
| Diabetes mellitus | 7 (29.1) |
| Insulin-dependent | 3 (12.5) |
| Congestive heart failure | 6 (25) |
| Peripheral vascular disease | 5 (20.8) |
| Chronic obstructive pulmonary disease | 3 (12.5) |
| Immunocompromised, No. (%) | 15 (62.5) |
| Solid organ transplant | 7 (29.1) |
| Kidney | 4 (16.7) |
| Lung | 2 (8.3) |
| Liver | 1 (4.2) |
| Bone marrow transplant | 3 (12.5) |
| Prednisone (≥5 mg/d) | 9 (37.5) |
| Calcineurin inhibitors | 6 (25) |
| Antiproliferative agents | 6 (25) |
| mTOR inhibitors | 1 (4.2) |
| CCI, median (IQR) | 7 (4.5–10) |
Abbreviations: CCI, Charlson Comorbidity Index; IQR, interquartile range; mTOR, mammalian target of rapamycin.